Koyfin Home > Directory > Health Care > Aimmune Therap > Levered Free Cash Flow (FCF)

Aimmune Therap Levered Free Cash Flow (FCF) Chart (AIMT)

Aimmune Therap annual/quarterly Levered Free Cash Flow (FCF) from 2015 to 2020.
  • Aimmune Therap Levered Free Cash Flow (FCF) for the quarter ending June 06, 2020 was $-33m a 0.55% decrease of 0m year over year
  • Aimmune Therap Levered Free Cash Flow (FCF) for the last 12 months ending June 06, 2020 was $-141m a 15.22% decrease of -21m year over year
  • Aimmune Therap Annual Levered Free Cash Flow (FCF) for 2019 was $-120m a 16.32% decrease of -20m from 2018
  • Aimmune Therap Annual Levered Free Cash Flow (FCF) for 2018 was $-100m a 39.33% decrease of -39m from 2017
  • Aimmune Therap Annual Levered Free Cash Flow (FCF) for 2017 was $-61m a 40.52% decrease of -25m from 2016
Other Cash Flow Metrics:
  • Aimmune Therap Cash Flow from Operations for the quarter ending September 09, 2018 was $-41m a 22.62% decrease of -9m year over year
View Chart On Koyfin

Quarterly AIMT Levered Free Cash Flow (FCF) Data

06/2020$-33m
03/2020$-49m
12/2019$-31m
09/2019$-33m
06/2019$-27m
03/2019$-29m
12/2018$-31m
09/2018$-25m
06/2018$-21m
03/2018$-24m

Annual AIMT Levered Free Cash Flow (FCF) Data

2019$-120m
2018$-100m
2017$-61m
2016$-36m
2015$-20m
2014$-6m